Leading science, pioneering therapies

CRM Publications

Found 6 results
Filters: Keyword is Severity of Illness Index  [Clear All Filters]
2014
Hall DP, MacCormick IJC, Phythian-Adams AT, Rzechorzek NM, Hope-Jones D, Cosens S, Jackson S, Bates MGD, Collier DJ, Hume DA et al..  2014.  Network analysis reveals distinct clinical syndromes underlying acute mountain sickness.PLoS One. 9(1):e81229.
2012
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du M-Q, Luan S-L, Altmann DR, Thompson AJ et al..  2012.  Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.Lancet Neurol. 11(2):150-6.
Kumar R, Rodriguez V, Matsumoto JMS, Khan SP, Weaver AL, McBane RD, Heit JA.  2012.  Development and initial validation of a questionnaire to diagnose the presence and severity of post-thrombotic syndrome in children.Pediatr Blood Cancer. 58(4):643-4.
2010
Anderson JMarian, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MGrazia, Chandran S.  2010.  Abnormal tau phosphorylation in primary progressive multiple sclerosis.Acta Neuropathol. 119(5):591-600.
Heun R, Gühne U, Luck T, Angermeyer MC, Ueberham U, Potluri R, Natalwala A, Arendt T, Riedel-Heller SG.  2010.  Apolipoprotein E allele 4 is not a sufficient or a necessary predictor of the development of Mild Cognitive Impairment.Eur Psychiatry. 25(1):15-8.
2009
Anderson JMarian, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MGrazia, Chandran S.  2009.  Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis.Acta Neuropathol. 117(5):583-9.